Its once again gonna be pharmaceutical companies' day out in the USA. The country is about to witness a gathering of tens of thousands of pharmaceutical industry professionals and technical experts, where innovative ideas will be diffused for the better future of the pharma industry. The platform for the meeting is nothing other than Interphex 2007, one of the mega pharmaceutical events in the world, to be held at the Jacob K Javits Convention Centre, New York. Organised under the aegis of Reed Exhibitions, the event will be held from April 24 to 26, 2007.
To all that it is worth, Interphex 2007, a three-day exhibition-cum-conference, will house exhibition of newest technologies, products and equipment and live demonstrations to make known the innovations in the pharmaceutical industry. The main objective of the event is diffusion of innovation, the kernel of any development activity.
It stands to reason that a suitable platform is required to showcase the newest of technologies, products and equipment, apart from a fertile ground for effective communication. And, no doubt, Interphex USA houses all these required facilities for the dissemination of advanced technologies and ideas related to the pharmaceutical industry.
The main attraction of Interphex 2007 will be the introduction of PharmaMedDevice. This new forum will address the needs of the emerging combination product market and the exciting innovations taking place in the drug delivery technology and the healthcare industry today. The event will have conference sessions centered on facilities, outsourcing and contract services, information technology and manufacturing/processing, all with respect to pharmaceutical industry. Interphex 2007 will also feature exhibition of technologies related to all these segments.
While pharma facilities segment will provide a complete picture of the need to create, operate and maintain a pharmaceutical research laboratory or production facility, pharma outsourcing and contract services segment will help one identify new partners to assist him in certain areas, including capacity concerns, conservation of capital and optimization of value chain. This segment will also assist one to evaluate potential partners for every stage of the pharmaceutical manufacturing process.
The pharma information technology segment will feature the tools and expertise required to connect laboratories, manufacturing, storage and distribution facilities, optimize business and manufacturing processes, integrate legacy systems and synchronize supply chain. The pharma IT segment is expected to showcase all the equipment needed to facilitate enterprise-wide collaboration. Organizers feel that it's high time that the pharmaceutical companies identified IT tools that can increase drug development efficiencies, enable rapid response to change and maintain regulatory compliance.
With innovative solutions for every stage of the manufacturing process, from process development and quality control to packaging and validation, the pharma manufacturing and processing segment is expected to display the most advanced equipment for mixing and blending, grinding, tableting, filtration, weighing and packaging. This segment will also present equipment for process automation and controls, which will help optimization of manufacturing process, enhancement of product quality and acceleration in delivery of new drugs to the market.
Key focus areas
Interphex 2007 is expected to focus on new solutions and sources for automation, packaging, radio frequency identification (RFID), contamination control and biotech.
The organizers pointed out that with the increasing pressure to reduce manufacturing costs and the food and drug administration's support for process analytical technology, the importance of automation in the pharmaceutical industry is stronger than ever. Hence, Interphex 2007 will provide an opportunity for sourcing the latest automation systems, instruments and controls to make manufacturing operations more efficient and productive, they added.
As one of the key focus areas, the RFID pavilion will feature state-of-the-art, industry specific solutions that will enable packaging process more productive, while safeguarding product efficacy. The RFID segment is expected to impart knowledge on how it can improve the integrity of the supply chain and patent safety, reduce counterfeiting, increase operational efficiency and protect brand.
Referring to the selection of contamination control as a key focus area of Interphex 2007, the organizers said, "It is one of the toughest challenges facing today's pharmaceutical and biopharmaceutical manufacturers. Industry trends indicate a rapid increase in the number of new biologicals and the development of powerful new cancer therapeutics. These developments are fueling increased demand for clean rooms, controlled environments, isolators and cleaning and monitoring equipment that can ensure high levels of sterility and product purity."
The event will help one to find everything that is needed to evaluate new products and technologies to meet increasingly stringent current good manufacturing practices (cGMP) requirements, they noted.
Interphex routines
As usual, Interphex USA will facilitate one-on-one meetings between industry professionals and technical experts, while providing a clear picture about the emerging trends in the pharmaceutical industry. The event will also be a suitable forum to get expert advice to specific challenges, find resources and source new products, all related to pharmaceutical industry. More than 1000 leading global players in the industry are expected to showcase the equipments, technologies, ideas and strategies at Interphex 2007. The telling aspect of the event is that it will optimise operations of pharma companies, from process development and R&D to manufacturing and packaging.
According to the organizers, the event will provide an unparalleled opportunity to view the latest products, technologies and services from the key players in the industry. The comprehensive conference programmes by experts, including Bill Cook, Chairman and CEO, Cook Group, Inc. and G. Steven Burrill, CEO, Burrill and Co., is expected to add to the tempo of the event.